Covid vaccine: How many people in the UK have been vaccinated so far?

Share this with Email Share this with Facebook Share this with Twitter Share this with Whatsapp

More than 32 million people in the UK have received at least one dose of a coronavirus vaccine - part of the biggest inoculation programme the country has ever launched.

In a race against a faster-spreading variant of the virus, ministers have pinned their hopes for further easing of a third national lockdown on vaccinating as many adults as possible by summer.

But vaccine supply issues and have continued to make the rollout bumpy.

Who can get a vaccine now?

The UK government aims to offer a first vaccine dose to about 32 million people in nine priority groups by 15 April.

The programme in England is now inviting those aged 50 and above to book appointments after the first four groups - those aged 70 and over, care home residents, healthcare workers and people required to shield - were offered a jab by mid-February.

These groups account for 88% of deaths so far.

Show More

If you can't see the lookup, click here

The over 50s in Scotland and Wales and the over 40s in Northern Ireland have been asked to book appointments.

The government then plans to begin vaccinating the rest of the adult population in age order, another 21 million people.

All people in their 40s will be next, once the current phase is completed.

More than 32 million people have had a first vaccine dose and over seven million have had a second.

The number of first doses administered each day is now averaging around 87,000 - a drop from an average of about 500,000 in mid-March - as the schedule of second doses kicks in.

An average of 317,000 second doses are now being given a day.

Despite an expected dip in vaccine supply in April, the government says the country is still on track to offer a first dose to everyone aged 50 and over by the end of the month, and to all adults by the end of July.

This will be helped by the rollout of a third approved vaccine, made by Moderna, which joined the vaccines being distributed in Wales and Scotland last week.

Those aged under 30 are to be offered the Moderna or Pfizer-BioNTech jabs as an alternative to the Oxford-AstraZeneca vaccine due to evidence linking it to rare blood clots.

Health Secretary Matt Hancock has said there is "more than enough of the Pfizer or Moderna vaccine" for the 8.5 million people under 30 who are yet to be vaccinated to have two doses.

The campaign to reach as many people as quickly as possible was boosted by a shift in policy in early January - to prioritise the first dose of a vaccine, with a second dose up to 12 weeks later, a bigger gap than originally planned.

The progress made in the UK so far means the country continues to be among those with the highest vaccination rates globally.

Has the rollout been even across all areas?

There continues to be some regional variation in the vaccine programme.

England, on average, has vaccinated 94% of those aged 50 and over, with the South West reaching 97% of people in that age group and London 86%.

In Scotland, 94% of over 50s have had at least one dose of the vaccine, while Wales has reached 88% and Northern Ireland 63%.

When looking at all those aged 18 and above, England, Scotland, Wales and Northern Ireland have all vaccinated more than half of adults with the first dose.

Second doses are also being rolled out. Wales has administered the second dose to 19% of adults, driven by the prioritisation of vaccines to those working in the health and care sectors.

There have also been disparities between ethnic groups and poorer and wealthier areas.

Analysis of NHS records by the OpenSAFELY group - a collaboration between Oxford University and the London School of Hygiene and Tropical Medicine - shows that black people were the least likely to have received a vaccine among five of the older age groups.

The study was based on more than 20 million patient records in England and covers people not living in care homes. Areas of London are under-represented in the data.

In addition, vaccine take-up in poorer areas is lower than in more affluent areas.

For example, 77% of those aged 55-59 in the poorest areas had been given a vaccine by 1 April, compared with 90% in the most affluent.

Where are the vaccines coming from?

The UK is now receiving doses of three vaccines approved by the medicine regulator.

The Pfizer-BioNTech jab - the first to be given the green light in December - is being imported from Puurs, Belgium.

A second vaccine, from Oxford University and AstraZeneca, is being made at a number of sites in Britain. Further doses are expected to come from the Serum Institute of India and the Halix plant in the Dutch city of Leiden.

The third, from Moderna, is coming from sites in Switzerland and Spain, via Belgium.

The UK is also lined up to receive at least three further vaccines if they are approved for use.

A jab manufactured by US firm Novavax will be made in Stockton-on-Tees in north-east England, while another by French company Valneva will be made in Livingston, West Lothian, Scotland.

The third, by Belgian firm Janssen, owned by Johnson & Johnson, should also be available later this year.

How will people be vaccinated?

People will be vaccinated in three main ways, at:

  • Local GP practices and community pharmacies
  • Hospital hubs
  • Major vaccination sites across the country

The government has urged the public to "play their part" in supporting "the largest vaccination programme in British history", including helping people attend their appointments.

Some vaccine centres will close temporarily in April as supply shortages kick in, while others will stop taking bookings for first dose appointments.

Is there enough vaccine?

The UK has ordered more than 400 million doses of seven of the most promising vaccines.

Three have so far been approved for use: Oxford-AstraZeneca; Pfizer-BioNTech; and Moderna.

The UK government has also announced an eighth deal with biopharmaceutical company CureVac to develop vaccines against future variants.

It has placed an initial order for 50 million doses to be delivered later this year - if they are required.

But there have been a number of challenges in what is called the vaccine "supply chain" - the logistics of how the jab gets from manufacturers to people.

Getting enough supplies, checking those supplies are up to scratch and transporting vaccines according to their requirements have all thrown up difficulties.

Will your vaccine appointment be the first time you have left home in a long while? Have you or your loved ones been making a special effort for the occasion? Send your photos or videos to .

Please include a contact number if you are willing to speak to a BBC journalist. You can also get in touch in the following ways:

Or please use the form below:

If you are reading this page and can't see the form you will need to visit the mobile version of the BBC website to submit your question or comment or you can email us at . Please include your name, age and location with any submission.